New York, US (PRWEB UK) 6 May 2015
Download the brief to gain an insightful look into genomic approaches: http://bit.ly/1EJio46
While it is too early to begin treating all cancer patients using genomic medicine, it is definitely the time to start its evidence base using the literature. Gain an insightful look into genomic approaches in a number of areas including:
The current role of genomic assessment in diagnosis, prognosis, and treatment of each cancer type
Genetic alterations that have been associated with each cancer and tumor types associated with each genetic alteration
Frequency of a mutation within a cancer type
Real-world practice patterns of use of targeted agents
Constellations of genetic changes that often occur together, and affected cellular pathways
About Truven Health Analytics
Truven Health Analytics delivers the answers that clients need to improve healthcare quality and access while reducing costs. We provide market-leading performance improvement built on data integrity and empirical truth. For more than 30 years, our insights and solutions have been providing hospitals and clinicians, employers and health plans, state and federal government agencies, life sciences companies, and policymakers the facts they need to make confident decisions that directly affect the health and well-being of people and organizations in the US and around the world.
Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan, 100 Top Hospitals, Advantage Suite, Micromedex, Simpler, ActionOI, JWA, and HeartbeatExperts which the company acquired in 2014. Truven Health has its principal offices in Ann Arbor, Mich.; Chicago; and Denver. For more information, please visit http://www.truvenhealth.com.